Statistics from the Regional Drug Misuse Databases for six months ending September 2000

Size: px
Start display at page:

Download "Statistics from the Regional Drug Misuse Databases for six months ending September 2000"

Transcription

1 Statistics from the Regional Drug Misuse Databases for six months ending September 2000 This bulletin summarises information on people presenting to services with problem drug misuse and relates to the six month period ending 30 September It is the ninth in the series to be based on more detailed data collected from Regional Drug Misuse Databases. The bulletin relates to ; some figures for Great Britain are also included. Summary Contents Pages In, during the six month period ending 30 September 2000: About 33,100 users were reported as presenting to drug misuse agencies; this is an increase of 4% from the previous six month period (31,800). Half (50%) of those users presenting were in their twenties and around one in seven (14%) were aged under 20, as in previous periods. The ratio of males to females (3:1) was also the same as in previous periods. Heroin was still the most frequently reported main drug of use, accounting for two thirds of users (64%). The next most frequently reported main drugs of misuse were methadone (10%), cannabis (9%), cocaine (6%) and amphetamines (4%). 1. Introduction 2 2. Trends in users and episodes 3. Drugs of misuse 5 4. Injecting and sharing behaviour 5. Agency of treatment 8 6. Regional Office areas and Health Authorities 7. Great Britain Tables Acknowledgements Editorial notes 10 Annexes A Information about the Regional Drug Misuse Databases B Tables 23 C Great Britain Tables 73 Bulletin 2001/18 Published June 2001 ISBN: Crown Copyright 2001

2 1. Introduction 1.1 In 1989, following recommendations from the Advisory Committee on the Misuse of Drugs, the Department of Health (DH) provided funding to the then Regional Health Authorities to set up databases to collect anonymised information about drug misusers attending a range of specialist services, and to return to the Department a six monthly aggregated dataset. 1.2 Information on people presenting to services with problem drug misuse for the first time, or for the first time for six months or more, is collected by the drug misuse agencies. Selected personal details and information regarding the drugs misused, together with the type of agency attended, are forwarded to the local Regional Drug Misuse Database (RDMD). RDMDs identify all the records received from agencies which contain attributable data from face to face contacts, counting those people who attended more than one agency in the RDMD area only once as users. A user may be recorded as having several episodes. 1.3 Since 1 April 1996, more detailed data have been submitted to DH. This Statistical Bulletin is the ninth publication of the extended dataset, and covers the period 1 April 2000 to 30 September More detailed information regarding the collection of this data, together with a Glossary of Terms, is included in Annex A. Most of this bulletin relates to, with detailed tables at Figure 1 Number of episodes per user for the period ending March 2000 Users Number of episodes Number Percentage 1 33, , Annex B. Some information for Great Britain is given at Annex C. 1.4 The Government s 10-Year Strategy Tackling drugs to build a better Britain was published in April A key objective is to Increase participation of problem drug misusers, including prisoners, in drug treatment programmes which have a positive impact on health and crime. The UK Anti-Drugs Co-ordinator published a national plan for 2000/01 in July 2000 and a report for 1999/00 in November 2000 (see Annex A.8). 1.5 Following a strategic review of the structure and operation of the RDMDs, the National Drugs Treatment Monitoring System was introduced in from 1 April A similar system has also been introduced in Wales. This new system will provide more useful information Total 35, and will contribute fully to the information needs of the Government s drugs strategy and other stakeholders. The new system will collect information on clients entering treatment; in addition, further information will be collected on each client at the end of each financial year (starting at 31 March 2002) including whether or not they are still in treatment. 1.6 A Statistical Bulletin Statistics on young people and drug misuse:, 1998 was published in July 2000 by DH (see Annex A.8). This draws on information from two key sources to monitor the objective of the 10-Year Strategy to help young people resist drug misuse. It includes information such as the proportion of young people offered drugs; the proportion of young people who had used drugs in the last year, the last month and types of drug used. 2 Statistical Bulletin 2001/18 June 2001

3 2. Trends in users and episodes 2.1 During the six month period ending 30 September 2000, there were 33,093 users reported as starting agency episodes, an increase of 4% on the previous period (31,815). Similarly, the number of agency episodes reported increased by 5% to 35,482 (compared to 33,789 in the previous period). As in the previous period, the vast majority of users (93%) had only one episode reported. (Table 1a and Figure 1). 2.2 Although the overall number of users increased compared to the previous period, there was much variation between RDMDs. For example, there were increases in the number of users reported by London (up 10%), West Midlands (up 8%) and South West (up 7%). However, there were small decreases in the number of users reported in Eastern (down 6%) and Trentg (down 4%). These changes may, at least in part, be due to changes in reporting practice. (Table 1b). 2.3 In the latest period, there were increases in the number of episodes reported for both statutory and non-statutory community based drug services (by 5% and 6% respectively). There has been a 12% increase in returns from General Practitioners to RDMDs. (Tables 10a and 10b and Figure 2). 2.4 For the six month period ending March 2000 RDMDs were, for the first time, specifically asked to exclude episodes for users treated for drug misuse in prison from the data sent to DH. This change in reporting practice affects comparisons between the periods ending September 1999 and March 2000; it is estimated that the numbers of users increased by 8% in this period (though the reported increase was 4%). Figure 2 Episodes reported by type of agency in the six month periods ending 30 September 1993 to 30 September ,000 16,000 Statutory CBDS Number of episodes 14,000 12,000 10,000 8,000 6,000 4,000 Non-Statutory CBDS Other Services 2,000 Police Surgeons GPs 0 Sept 1993 Mar 1994 Sept 1994 Mar 1995 Sept 1995 Mar 1996 Sept 1996 Mar 1997 Sept 1997 Mar 1998 Sept 1998 Mar 1999 Sept 1999 Mar 2000 Sept 2000 Six month period ending Statistical Bulletin 2001/18 June

4 2.5 It is thought that the decrease in reporting seen for some agency types in the period ending September 1997 is likely to be due to changes in reporting practice following the closure of the Addicts Index (see Annex A1.1). It is important that the changes in reporting practice are borne in mind when interpreting the results in this bulletin. Age and gender of users 2.6 The gender distribution of users showed a male to female ratio of 3:1, overall, which is similar to previous periods. Figure 4 Number of drugs of misuse per user for the period ending September 2000 Number of Users drugs misused number Percentage 1 15, , , , ,267 4 Total 33, A half of all users (50%) are in their twenties, with one in seven (14%) aged under 20 and around a third (36%) aged 30 and over. (Tables 2a, 2b and Figure 3). For the period ending September 2000, the largest increase in users was in the 30 and over age group (up by 10% compared with an increase of 4% for all ages). Figure 3 Age and gender of users starting agency episodes in the six months ending 30 September ,000 6,000 5,000 4,000 3,000 2,000 1,000 0 Under to to to to to to to to to to & Over Number of episodes Male Female Age 4 Statistical Bulletin 2001/18 June 2001

5 3 Drugs of misuse 3.1 Users must have one drug of misuse recorded and may be recorded as misusing a maximum of five drugs; one drug is recorded as the main drug of misuse, any others are recorded as subsidiary drugs. Just under half (46%) were recorded as misusing only one drug, over one quarter (28%) two drugs, just under one sixth (15%) three drugs, one in fourteen (7%) four drugs and one in twenty-five users (4%) were recorded as having five drugs of misuse. These figures are similar to previous periods. (Figure 4) 3.2 Some of the analysis in the bulletin is based on the "main drug" of misuse and some based on "all drugs" misused. The drugs of misuse have been grouped into drug categories in this bulletin, for ease of presentation and consistency with previous publications. Where a user reported misusing more than one drug in the same category (for example, diazepam and temazepam in the benzodiazepine category), the user has been counted once for this drug category when analysing all drugs misused. Main drug of misuse 3.3 Heroin was the most frequently reported main drug again, accounting for 64% of users. The percentage share has increased from 46% in the period ending September Conversely, the proportion reporting methadone as a main drug has decreased and was 10% in the period ending September (Tables 3a and 3b) 3.4 The proportion of GPs, police surgeons and Drug Dependency Units reporting users with methadone as a main drug (at 24%, 16% and 24% respectively) were higher than the figure of 10% for all users. This may have been due to methadone being prescribed for treatment and then being classed as a main drug; this may happen if the main problem drug is heroin, but heroin had not been used in the previous four weeks. The definition of a main problem drug has been changed following the introduction of the new National Drugs Treatment Monitoring System. (see paragraph 1.5) 3.5 The proportion reporting cannabis as a main drug was 9% in the latest period; cocaine was reported as a main drug by 6% of users. The proportion of users reporting amphetamines has remained constant at 4% since the last reporting period. (Table 3a and figure 5) All drugs of misuse 3.6 Taking all drugs of misuse reported (in first episodes only) into account, heroin remains the drug category with the largest Figure 5 Users starting agency episodes for main drug of misuse by category in the period 1 April 2000 to 30 September 2000 Amphetamines 4% Cocaine 6% Cannabis 9% Methadone 10% All Others 7% Heroin 64% Statistical Bulletin 2001/18 June

6 number of users. The proportion of users reported misusing heroin was 71% in the period ending September Over a quarter of users reported misusing cannabis (27%) and around one in five of users reported misusing cocaine (21%). 3.7 Since the period ending March 1998 there has been an increase in the proportion of users reported misusing heroin (from 65% to 71%) and cocaine (17% to 21%). Conversely, there has been a decrease in the proportion of users reporting methadone (from 23% to 18%) (see paragraph 3.4) and amphetamines (from 16% to 8%). (Table 7a) Subsidiary drugs of misuse 3.8 Looking at all drugs of misuse by category, there were a total of 62,790 reports; note that where a user reported misusing more than one drug in a category, this is counted as one report of the category here. Subsidiary use accounted for around half (29,697 reports or 47%) of all the drugs used. 3.9 Within each drug category, the proportion of all drugs that are reported as subsidiary drugs varies widely. A total of 23,513 users reported misusing heroin, but only 10% of these heroin users (2,279) reported misusing it as a subsidiary drug. However, some drugs were more likely to be reported as a subsidiary drug than as a main drug. Drugs reported mostly as subsidiary drugs include benzodiazepines (88% of the total of 5,207 users), cannabis (65% of the 8,785 users), cocaine (70% of the 6,830 users) and ecstasy (73% of the 1,598 users). Alcohol is, by definition, a subsidiary drug of misuse. See Glossary of terms and data definitions in Annex A.5. (Table 8) Age and gender of users and their main drug of misuse 3.10 The pattern of drug misuse (in terms of main drug used) is broadly similar for males and females. For example, the proportions of males and females reporting heroin as their main drug of misuse were 65% and 62% respectively. One exception is cannabis, which is more likely to be reported as a main drug of misuse by men (10%) compared to women (6%). (Table 4) 3.11 For some drugs of misuse, for example heroin, there was no clear pattern by age group. However, the use of methadone as a main drug increases with age; for example, 2% of those aged under 20 reported methadone as their main drug compared to 15% of those aged 30 and over (see also paragraph 3.4). Cannabis use was more likely to be reported by those aged under 20, compared to those aged 30 or over (28% and 6% respectively). The majority of solvent users recorded were aged under 20; the under 20s made up 62% of all who reported misusing solvents as their main drug. (Table 5) Drug routes 3.12 Drugs can be misused by a variety of routes, injecting being just one of them. The route recorded for each specific drug determines the classification of the user s injecting behaviour for the corresponding drug category. Users may report misusing more than one drug in the same drug category, but by different routes. Users are classified as "Injecting" for each drug category if they inject any drug in the category and others are classified with an injecting status of "Not known" if any drug route is unknown; the remaining users are classified as "Not injecting" The proportion of users injecting their main drug of misuse, of those whose injecting status was known, was broadly unchanged across all drug categories from the previous period. About two-fifths (41%) of users reported injecting their main drug; 58% of heroin users and 41% of amphetamine users were recorded as injecting their main drug. Similarly, for all drugs of misuse, 58% and 39% of heroin and amphetamine users respectively reported injecting their drug. (Tables 6 and 7b) 4. Injecting and sharing behaviour 4.1 Data regarding a user's injecting behaviour are collected in two different ways. The route by which drugs are taken is recorded for each drug of misuse (up to a maximum of five). (See paragraphs 3.1 and 3.12 above.) Other questions are asked to identify user behaviour; has the user injected drugs in the last four weeks, and if so, did the user share injecting equipment in the last four weeks. Users are also asked if they have ever injected drugs and if so, if they have ever shared injecting equipment. 6 Statistical Bulletin 2001/18 June 2001

7 Statistical Bulletin 2001/18 June

8 4.2 Of those whose injecting status was known, 66% of users had ever injected, whereas the corresponding figure for users injecting in the last four weeks was 45%. These are similar to the levels of the previous period. (Tables 9a and 9b) 4.3 Men were more likely to have injected in the last four weeks than women (47% compared to 40%); injecting was also less common among younger users only a third of users (31%) aged under 20 had injected in the last four weeks, compared to nearly half (46%) of those aged 30 and over. (Tables 9e and 9f) 4.4 The percentage of users who had ever shared injecting equipment, of those known to have injected and whose sharing status was known, was 50% compared to 42% in the six months ending September 1996; the equivalent figure for the last four weeks was 21%, compared with 12% in the six months ending September (Tables 9c and 9d) 4.5 Hunter and Stimpson (1998), however, found that a range of detailed questions elicited higher reports of sharing than a single question. As the RDMD information is based on a single question, the RDMD results should be treated with caution; they are likely to underestimate the true rate of sharing compared with the result from Stimpson s Injecting Risk Questionnaire (see Annex A.8). 4.6 Further analysis of drug misusers who had injected in the past four weeks indicates that women were more likely to have shared than men (25% compared to 20%), although it should be noted that women were less likely than men to have injected in the last four weeks. Younger users were more likely to have shared than older users (29% of those under 20 compared to 18% of those 30 and over), but again it should be noted that older users were more likely to have injected in the last four weeks. (Tables 9g and 9h) 4.7 This information on injecting and sharing should be treated with some caution since some users were recorded as having an injecting status of "Not known" ever (12%) and in the last four weeks (10%). Of those known to have injected, again some users reported their sharing status as "Not known" ever and in the last four weeks (17% and 13% respectively). (Tables 9a-9d) 5. Agency of treatment 5.1 Nearly half (48%) of the 35,482 new agency episodes reported were from statutory community based drug services (CBDS). Most others were from non-statutory CBDS (31%), outpatient drug dependency units (DDUs) (5%) and NHS funded general practices (6%). As discussed earlier (paragraph ), the changes in recent periods may be due in part to changes in reporting practice. (Tables 10a and 10b) 6. Regional Office areas and Health Authorities of treatment and residence 6.1 Information by Regional Office (RO) area and Health Authority (HA) of treatment, that is, the HA in which the user presents and is treated, is given in Tables and Maps 1 and 2. Tables 16a and 16b compare the HA of treatment with the user's HA of residence. Health Authority of treatment 6.2 Differences at HA of treatment level may be a reflection of the variations in demand for services or the pattern of provision, and not necessarily an indication of drug misuse in the local community. 6.3 Numbers of users at HA level are not comparable with published data up to the period ending March 1996 due to changes in the way in which data were collected and presented after this date (see Annex A.4). 6.4 The gender distribution characteristics displayed by the RO areas follow the pattern of at large, ie a 3:1 male to female ratio. More variation can be seen at HA level. (Table 11a) 6.5 Regional Office areas were restructured from 1 April 1999 and the tables in this bulletin are based on the new regional structure. 6.6 Rates for users per 100,000 population vary widely across the Health Authorities. Northern and Yorkshire RO area had the highest rate for users of all ages and the highest rates for users in 8 Statistical Bulletin 2001/18 June 2001

9 Statistical Bulletin 2001/18 June

10 all age bands under 30. London has the highest rates for users over 30. (see also Annex A.5.5 and tables 12a, 12b, 12c and Map 1). 6.7 Heroin was the most frequently reported main drug in all RO areas and most HAs. (Table 13) 6.8 The injecting and sharing statuses of users in the last four weeks varied across the RO areas. These figures on injecting and sharing need to be interpreted with care because some HAs of treatment had a relatively high proportion of users with no information recorded on injecting or sharing status in last 4 weeks. (Tables 14a, 14b and Map 2) Health Authority of residence 6.9 Information on HA of residence was collected by the Department of Health from the RDMDs for the first time for the period April to September This bulletin includes information on HA of residence in relation to HA of treatment. It should be noted that information on HA of residence was not available for 4% of users in the period ending September 2000 (Tables 16a and 16b) The tables show the number and percentage of users who have the same HA of residence as HA of treatment (that is, users resident in their HA of treatment); same RO of residence as HA of treatment, but different HA of residence (that is users resident in the same RO area as their HA of treatment, but not the same HA); different RO of residence to HA of treatment (that is, users resident in a different RO area from that of their HA of treatment); HA of residence not known (that is, users where the HA of residence has not been recorded) These tables show that the majority of users were treated in the HA in which they were resident There is still wide variation in the amount of data on HAs of residence that is missing and this must be borne in mind when interpreting the data in the tables. 7. Great Britain Tables 7.1 Information for users treated in, Wales and Scotland is given in Annex C, Tables C1 to C8.s given in Annex C, Tables C1 to C8 7.2 Some caution is needed in interpreting these tables. Differences between, Wales and Scotland may reflect variations in demand for services or the pattern of provision. In addition, there may be variations in reporting practice. 8. Acknowledgements 8.1 The Department would like to thank all the people involved in collecting the data presented in this bulletin - the Database Managers and their staff, and of course, all the agencies who have collected and sent in their data. The continued success of these bulletins depends on the continued cooperation of all these people in what is an important, if difficult and complex, area. 9. Editorial notes 9.1 Data were first collected centrally for the period ending 31 March However, these data are not directly comparable with later data. In this bulletin the data in the majority of the tables are given from the period ending 30 September 1993 and for the periods ending 31 March 1998 to 30 September The data for the periods ending 31 March 1994 to 30 September March 1997 have already been published in previous bulletins in this series. Note that some comparisons between data for the periods ending September 1996 onwards, with earlier periods, are not valid - see Annex A.4.6 for further details. 9.2 For the purposes of clarity, figures in the bulletin are shown in accordance with the Department of Health's publication conventions. These are as follows:. not applicable.. not available - zero 0 less than 0.5 numbers greater than or equal to 0.5 are rounded to the nearest integer. 10 Statistical Bulletin 2001/18 June 2001

11 9.3 Percentages do not always add to 100 due to rounding. 9.4 Constructive comments on the content of this bulletin would be welcomed. Any comments or questions concerning the data contained in this publication, or requests for further information, should be addressed to: information about sources, publications and contact points on the full range of government statistics. This website may be found at statbase/mainmenu.asp Patsy Bailey (Room 437B) Department of Health Skipton House 80 London Road London SE1 6LH Tel Fax Further copies of this publication can be obtained from: Department of Health PO Box 777 London SE1 6XH Tel Fax A list of references is given at Annex A Information about the Department of Health s statistics and surveys is available on the Internet at The website includes a full list of the DH s drug misuse statistical publications. Many of the publications (including this one) are available for viewing on-line. 9.8 The Government Statistical Service also offers an Internet site called StatBase. Statbase has been set up to provide Statistical Bulletin 2001/18 June

12 12 Statistical Bulletin 2001/18 June 2001

13 Annex A Information about the Regional Drug Misuse Databases Contents A.1. A.2. A.3. A.4. A.5. A.6. A.7. A.8. Background The origins of the collection of drug misuse data The Department of Health and the Regional Drug Misuse Databases Treatment of multiple episodes and comparability with previous bulletin Glossary of terms and data definitions Regional Drug Misuse Database Contacts Other contacts References Statistical Bulletin 2001/18 June

14 14 Statistical Bulletin 2001/18 June 2001

15 A.1 Background A.1.1 Before the development of the Regional Drug Misuse Databases very little information was held centrally regarding users of drug misuse services and the types of services used. Much of the difficulty in obtaining information lies with the illegal nature of drug misuse. Some data were available regarding hospital in-patients with drug related diagnoses. General Practitioners and other doctors provided the Home Office with details of patients who were addicted to drugs in accordance with the Misuse of Drugs Act 1971 (1973 Regulations); details were published annually in the Home Office Addicts Index until its closure in March The last publication was the Home Office Statistical Bulletin: Statistics of drug addicts notified to the Home Office, United Kingdom, 1996, published in October The data from the RDMDs are now the only routinely collected information about drug misuse services. A.1.2 The Department of Health collects drug misuse information from a range of drug treatment agencies. This information assists in the understanding of both national and local drug misuse problems. It is used for the planning and development of services, ensuring wherever possible that appropriate services are developed and that they respond effectively to changing trends in drug misuse. Data on injecting behaviour is particularly important because of its potential as a transmission route for HIV and hepatitis C. A.1.3 Drug users presenting to services for problem drug misuse only constitute a small proportion of all drug users. For a broader picture of patterns of drug misuse, surveys of selfreported drug use can be helpful, for example, the British Crime Survey (see Annex A.8). A.2 The origins of the collection of drug misuse data A.2.1 In 1982 the Advisory Council on the Misuse of Drugs (ACMD) published a report: "Treatment and Rehabilitation", which recommended that local drug teams be set up to collect information. Responding to this recommendation, the Department of Health issued circular HC(84)14 to the NHS requesting a review of the prevalence of drug misuse. In 1986 a drug misuse database was developed by the Drug Research Unit at the University of Manchester. In 1989 the Department commissioned the Unit to adapt the database for use by the NHS Regional Health Authorities (RHAs), and issued circular HC(89)30 requesting the RHAs to set up databases to monitor trends in drug misuse and the use of drug misuse services, and to introduce a system for providing this information to the Department by way of the KO71 Statistical Return. A.2.2 RHAs subsequently submitted one KO71 paper form for each of its District Health Authorities (DHAs) and Special Health Authorities (SHAs) within its geographical boundary, together with an overall KO71R form for the whole region with identifiable multiple counting of users across DHAs removed, biannually for each six month period 1 April to 30 September, and 1 October to 31 March respectively. The information provided on the forms comprised details of the relevant DHA, SHA or RHA of treatment; the numbers, by age and by sex, of users starting an agency episode, that is for the first time ever or for the first time after a gap of at least six months, during the period being monitored; the numbers of users by types of drugs being misused and whether these were being injected; and the numbers of episodes recorded at each type of drug misuse agency. Only data from face-to-face contacts where the initials, date of birth and sex were given (attributable data) were included. Data from certain agencies were excluded (probation services, social services, needle exchange schemes, outreach work and penal establishments) as the methods of collection utilised were not consistent. A.2.3 In July 1996 the Department issued an executive letter EL(96)54: Regional Drug Misuse Databases: Core Contract Specification, which sets out the current requirements of the extended national dataset. Beginning with the period 1 April to 30 September 1996 the Regional databases now submit anonymised details of individual users in electronic form. This includes age, sex and other personal information, details of up to five drugs misused, information regarding injecting/ Statistical Bulletin 2001/18 June

16 sharing equipment behaviour, treatment profiles, together with the type of agency attended and Health Authority (HA) of treatment. A.2.4 Some information was collected by the Department of Health from RDMDs for the first time for the period April to September 1996, but has not been included in this Statistical Bulletin. This includes ethnic group and employment status. There is a considerable amount of missing information, for example, details of ethnicity were missing for 14% of episodes. It was felt that analysis of these data might be misleading. It is hoped that the completeness of all data items collected by the Department of Health will improve over time and that further analyses will be included in future Statistical Bulletins. A.3 The Department of Health and the Regional Drug Misuse Databases A.3.1 The Department of Health meets regularly with the Regional Drug Misuse Database Managers and colleagues at the National Forum on Drug Data (NFDD), and also have strong links with the Database Managers' own forum, Network DMD. A.4 Treatment of multiple episodes and comparability with previous bulletin A.4.1 Only those people who present to a contributing drug agency for the first time ever, or for the first time after an interval of at least six months, providing attributable details including information concerning at least one drug of misuse (other than alcohol) are counted as users. (See Glossary of terms, at A.5.1, for definition of a User). A.4.2 An episode occurs each time a user presents to a particular agency for the first time, or returns to an agency after an interval of six months or more, and a report is made to the Regional Database. Every user must therefore have at least one episode and some may have several in one six month period (if they present to more than one agency within the same RDMD area in one six month period). A.4.3 During a reporting period users may commence several episodes, though not necessarily with the same HA, or even within the same Regional Office (RO) area. However, the way in which information about users with multiple episodes is treated in this Bulletin differs in some respects from the way in which data were collected and presented prior to March A.4.4 Up to March 1996, data were collected on an aggregate return, the KO71; this collected total numbers, rather than information about individuals. The KO71 was completed for each HA and recorded users and episodes; where a user had more than one episode starting in the HA, these episodes were linked to ensure that users were counted no more than once. A.4.5 At RDMD level an additional return, the KO71R was completed in which any counting of users more than once across the RDMD area was removed, since on the KO71R a user might have several episodes in the RDMD area, in one or more HAs. The totals for users were calculated by the Department of Health using the information from the KO71R returns, that is, they eliminated the counting of users more than once within each RDMD area (but not between RDMD areas). A.4.6 From April 1996 onwards, the RDMDs have supplied individual records to the Department of Health. Where a user has more than one episode in the RDMD area in a period, these episodes are linked when reported to DH as several episodes of one user. In Bulletins since the period April to September 1996, the analysis of users is based on the first (or only) episode of each user. Thus a user is counted at HA level, if and only if, their first episode was in that HA. A.4.7 Therefore, comparisons of users at HA level between the period April - September 1996 and later with previous bulletins are not valid; although comparisons of episodes at this level are. Comparison of numbers of users and episodes at RDMD level and with earlier data are valid. A.4.8 If an RO area consists of more than one RDMD, then despite users being counted only once within each RDMD, they may be counted more than once in the RO area because they are counted in each RDMD area. Thus the totals for RO areas are only true for those areas covered by one RDMD. In this bulletin, 16 Statistical Bulletin 2001/18 June 2001

17 no attempt has been made to eliminate double counting across two RDMDs in the same RO area. A.5 Glossary of terms and data definitions A.5.1 User A person who experiences social, psychological, physical or legal problems related to intoxication and/or regular excessive consumption and/or dependence as a consequence of his/her own use of drugs or other chemical substances. A.5.2 Agency A separately identifiable facility which provides a service to drug misusers. In practice some organisations may have more than one kind of facility each offering a different kind of service for different stages of treatment. A new episode should be recorded for each such facility rather than just one for the parent organisation. For example, if a particular organisation runs a residential facility and a day care facility and a user attends both, both facilities should make a return to the database for that user when a new episode starts. This information should then be carried forward to the central return treating the two facilities as two separate agencies. A.5.3 Classification of agencies When deciding which agency type should be used to describe a new episode it is important to consider the service offered rather than the role of the worker who sees the client. For example, if a client sees his General Practitioner at his GP's surgery, this counts as a General Practice agency episode. If the client sees a GP, even the same GP, at a Community Drug Team this counts as a Community Based Drug Service episode. A.5.4 All agency episodes starting during the period should be counted for the HA in which the agency is located and against the appropriate agency type. A.5.5 Agency types to be included in submission to DH In general, all agencies which lie within the geographical boundary of the area covered by the RDMD, whether they are private, voluntary, local authority or other should be included. In the interests of achieving good quality local and national statistics only fully attributable data should be included, that is, data for clients whose initials (forename and surname), date of birth and sex have been recorded by the agencies. A.5.6 In the interests of achieving good quality data comparable across the country, some agency types listed should be excluded from the return to DH. Regions are, of course, free to collect data from these agencies on their own databases as long as the data can be filtered out when submitting the central return. A.5.7 The agency types to be excluded from the submission to DH are: Needle exchange schemes Outreach work (Outreach workers who are working in other areas where a report would normally be made should be included. Actual outreach work should be excluded.) Probation service Social Services Penal establishments (prisons and young offenders institutions) Telephone and letter contacts Third party contacts A.5.8 Up to the period ending September 1999, some RDMDs included in their submission to DH episodes relating to the work of specialist community agencies in prison. For the periods ending March 2000 onwards, RDMDs have been asked to exclude these prison episodes. This needs to be taken into consideration when comparing the periods ending March 2000 onwards, with earlier periods (see also paragraph 2.4). A.5.9 Agency Episode An agency episode starts when a user goes to a particular agency for the first time, or returns to an agency after an interval of 6 months or more. Whenever a new episode starts, a report is made by the agency to the regional database. One user can have several concurrent episodes. A.5.10 Drug Any drug of misuse, including solvents and tranquillisers but excluding tobacco; alcohol as the sole drug of misuse should be excluded. Where alcohol is part of the drug profile it should be included but always as a subsidiary drug, that is, second or subsequent drug, not the main drug. Note that in bulletins prior to the period ending March 1999 a few misusers were recorded as "Drug free". These users were Statistical Bulletin 2001/18 June

18 drug free when they presented to services and no information on previous drug misuse was recorded. In bulletins prior to period ending September 1996 such users were shown as "Not known". In this period information was obtained on previous drug misuse for all users. any analysis upon this data would be misleading. A.5.11 Mandatory fields The following fields are mandatory; a valid code must be given, the fields must not be left blank: Database Number Episode Number Age Sex Drug Code (Main Drug only) Agency Type Agency HA Code Non-mandatory fields may be left blank if the information is not available. A.5.12 Other information collected Information was also collected on the following: Ethnic group Employment status Referral from Dependent children (living with client, elsewhere, in care or unspecified residence) Living with relationship Whether drug of misuse prescribed How often taken Duration of episode Age of first use Intent on prescribing However, the data were not well supplied for all these fields. Where a large proportion of the data was missing, it was felt that 18 Statistical Bulletin 2001/18 June 2001

19 A.6 Regional Drug Misuse Database Contacts A.6.1 Contact details for the Regional Drug Misuse Databases are given below. The National Drugs Treatment Monitoring System was introduced in from 1 April 2001 (see paragraph 1.5); consequently some Regional Databases have recently been renamed. The Database Managers can provide further information for their own database on request. Northern & Yorkshire Duncan Easton Database Manager Leeds Addiction Unit 19 Springfield Mount Leeds LS2 9NG Tel: Fax: duncanea@lau.co.uk Trent Ian Ball Manager National Drug Treatment Monitoring System-Trent Drury House 50 Leicester Road Narborough Leicester LE9 5DF Tel: Fax: DruryHse@freenet.co.uk South East (West) and Eastern Bryony Brown Manager Drugs Treatment Monitoring Unit South East (W) and Eastern Public Health Resource Unit Institute of Health Sciences Old Road Headington Oxford OX3 7LF Tel: Fax: drug.database@phru.anglox.nhs.uk Thames/ Southeast (East) Paul Eastwood National Drug Treatment Monitoring System-Thames/ Southeast (East) The Centre for Research on Drug & Health Behaviour Imperial College School of Medicine Reynolds Building Charing Cross Campus St Dunstan's Road London W6 8RP Tel: Fax: p.eastwood@ic.ac.uk South West (including Wessex) Barbara Boulton Manager National Drug Treatment Monitoring System-South West Oakwood House Blackberry Hill Hospital Fishpond Bristol BS16 2EW Tel: Fax: Barbara.Boulton@awwt.swest. nhs.uk West Midlands Jennie Lowdell National Drug Treatment Monitoring System - West Midlands 3 rd Floor, West House Lombard Street West West Bromwich West Midlands B70 8ER Tel: Fax: dmdproj@hsrc.org.uk North West Mersey: Dr Caryl Beynon Public Health Sector School of Health and Human Sciences Liverpool John Moores University 70 Great Crosshall Street Liverpool L3 2AB Tel: Fax: C.M.Beynon@livjm.ac.uk North Western: Petra Meier University of Manchester Drug Misuse Research Unit School of Epidemiology & Health Services Kenyon House Bury New Road Manchester M25 3BL Tel: Fax: petra.meier@man.ac.uk Statistical Bulletin 2001/18 June

20 A.7 Other Contacts A.7.1 For statistical information for Scotland, please contact: Elaine Parry Scottish Drug Misuse Database Information & Statistics Division Trinity Park House South Trinity Road Edinburgh EH5 3SQ Tel: Fax: k and.org A.7.2 For statistical information for Wales, please contact: Nadine Bami National Assembly for Wales Substance Misuse Implementation Branch Cathays Park Cardiff CF10 3NQ Tel: Fax: k A.7.3 Northern Ireland set up a Drug Misuse Database in April Results are expected to be available for the six month period ending September For further information, please contact: Kieron Moore Information and Analysis Unit Department of Health Social Services and Public Safety Room 6, Annex 2 Castle Buildings Newtonards Road Belfast BT4 3UD Tel: kieron.moore@ DHSSPSNI.gov.uk A.7.4 For statistical information about the Home Office Addicts Index, please contact: John Corkery Research & Statistics Directorate Home Office 50 Queen Anne's Gate London SW1E 9AT Tel: john.corkery@homeoffice.gsi.g ov.uk A.7.5 For information regarding the Drug Misuse Database system, please contact: Dr Michael Donmall University of Manchester Drug Misuse Research Unit School of Epidemiology & Health Services Kenyon House Bury New Road Manchester M25 3BL Tel: Fax: m.donmall@man.ac.uk k/epidem/homepage.htm A.7.6 For information about the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), please contact: EMCDDA Rua da Cruz de Santa Apolonia 23/25 PI Lisbon Portugal Tel: Fax: info@emcdda.org 20 Statistical Bulletin 2001/18 June 2001

21 A.8 References 1. Tackling Drugs to Build a Better Britain. The Government s 10-year Strategy for Tackling Drug Misuse. Cm London: The Stationery Office, (ISBN ) 2. The United Kingdom Anti-drugs Co-ordinator s First Annual Report and Action Plan, Central Office of Information, May The United Kingdom Anti-drugs Co-ordinator s Second National Plan, Central Office of Information, July The United Kingdom Anti-drugs Co-ordinator s Annual Report and National Plan 1999, Statistics on young people and drug misuse: London: Department of Health, Statistical Bulletin 2000/18. Telephone Ramsay, M. & Percy, A. Drug Misuse Declared in 1994: latest results from the British Crime Survey. London: Home Office, (Home Office Research Study 151). Telephone Ramsay, M. & Spiller, J. Drug Misuse Declared in 1996: latest results from the British Crime Survey. London: Home Office, (Home Office Research Study 172). Telephone Ramsay, M. & Partridge, S. Drug Misuse Declared in 1998: latest results from the British Crime Survey. London: Home Office, (Home Office Research Study 1997). Telephone Goddard, E. & Higgins, V. Smoking, drinking and drug use among young teenagers in 1998 Volume 1:. London: The Stationery Office, ISBN Drug use, smoking and drinking among young teenagers in 1999 First Release, Office for National Statistics, May Drug use, smoking and drinking among young teenagers in London: The Stationery Office, November (ISBN ). Statistical press release on Hunter, G. and Stimpson, G. Survey of prevalence of sharing by injecting drug users not in contact with services. Imperial College School of Medicine, Statistical Bulletin: Statistics of drug addicts notified to the Home Office, United Kingdom, London: Home Office, Statistical Bulletin 2001/18 June

22 22 Statistical Bulletin 2001/18 June 2001

23 Annex B Tables Index Tables 1 to 10b show figures for as a whole, tables 11 to 16 give information for each Regional Office area and Health Authority of treatment. Tables are for the six month period 1 April to 30 September 2000 unless otherwise stated. ENGLAND Table 1a: Table 1b: Table 2a: Table 2b: Table 3a: Table 3b: Table 4: Table 5: Table 6: Table 7a: Table 7b: Table 8: Table 9a: Table 9b: Table 9c: Table 9d: Users and agency episodes (periods ending 30 September 1993 onwards) Users starting agency episodes by Regional Office area (period ending 30 September 1999 onwards) Age and gender of users - numbers (periods ending 30 September 1993 and 31 March 1998 onwards) Age and gender of users - percentages Main drug of misuse (periods ending 30 September 1993 and 31 March 1998 onwards) Main drug of misuse and agency type Main drug of misuse by gender Main drug of misuse by age group Main drug of misuse and whether injecting All drugs of misuse (periods ending 30 September 1993 and 31 March 1998 onwards) All drugs of misuse and whether injecting Main and subsidiary drugs of misuse Injecting behaviour in the last four weeks (periods ending 30 September 1993 onwards) Injecting behaviour ever (periods ending 31 March 1996 onwards) Sharing behaviour in the last four weeks (periods ending 30 September 1993 onwards) Sharing behaviour ever (periods ending 31 March 1996 onwards) Table 9e: Injecting behaviour in the last four weeks by gender continued... Statistical Bulletin 2001/18 June

24 Table 9f: Table 9g: Table 9h: Table 10a: Injecting behaviour in the last four weeks by age Sharing behaviour in the last four weeks by gender Sharing behaviour in the last four weeks by age Agency episodes by type of agency - numbers (periods ending 30 September 1993 and 31 March 1998 onwards) Table 10b: Agency episodes by type of agency - percentages (periods ending 30 September 1993 and 31 March 1998 onwards) REGIONAL OFFICE AREA AND HEALTH AUTHORITY OF TREATMENT Table 11: Table 12a: Table 12b: Table 12c: Table 13: Table 14a: Table 14b: Table 15: Table 16a: Table 16b: Gender of users Age group of users - numbers Age group of users - percentages Age group of users - rates per 100,000 population Main drug of misuse (heroin, methadone, cannabis, cocaine, amphetamines and all other drugs) Injecting behaviour of users in the last four weeks Sharing behaviour of users in the last four weeks Agency episodes by type of agency Health Authority and Regional Office of residence - numbers Health Authority and Regional Office of residence - percentage 24 Statistical Bulletin 2001/18 June 2001

25 Table 1a. Users starting agency episodes (by gender) and agency episodes, in the periods ending 30 September 1993 to 30 September 2000 numbers Users Agency Ratio of Six month period ending Persons Males Females episodes (1) episodes to users 30 Sept ,810 12,556 4,254 17, March ,864 13,501 4,363 19, Sept ,331 14,443 4,888 20, March ,733 15,792 4,941 22, Sept ,848 17,218 5,630 24, March ,313 17,680 5,633 25, Sept ,879 18,763 6,116 27, March ,925 19,670 6,255 28, Sept ,996 16,463 5,533 23, March ,916 18,055 5,861 25, Sept ,599 21,343 7,256 29, March ,499 21,428 7,071 29, Sept ,545 22,925 7,620 32, March ,815 23,635 8,180 33, Sept ,093 24,332 8,761 35, Percentage change between periods ending 31 March 2000 and 30 Sept 2000 (2) +4.0% +2.9% +7.1% +5.0% 1. The number of agency episodes is generally greater than the number of users as a person may start an episode during the period at more than one agency.

26 Table 1b. Users starting agency episodes by Regional Office area of treatment during the periods ending 30 September 1999 to 30 September 2000 numbers Six month period ending 30 Sept 31 March 30 Sept RO area (1) ,545 31,815 33,093 Northern and Yorkshire 6,395 6,133 6,464 Trent 3,622 3,548 3,423 Eastern 2,537 2,515 2,356 London 5,632 6,040 6,626 South East 2,860 3,193 3,304 South West 3,005 3,022 3,247 West Midlands 2,139 2,381 2,572 North West 4,355 4,983 5,101 Percentage change between periods ending 30 Sept March 2000 to to RO area 31 March 2000 (1) 30 Sept Northern and Yorkshire Trent -2-4 Eastern -1-6 London South East South West West Midlands North West There was a change in reporting practice for the period ending March RDMDs were specifically asked to exclude 'prison episodes' from their submission of data to DH. Taking account of these 'prison episodes', the number of episodes increased by around 8% between the periods ending Sept 1999 and March 2000 (see also paragraph 2.4)

27 Table 2a. Age and gender of users starting agency episodes in the periods ending 30 September 1993, and periods ending 31 March 1998 to 30 September 2000 numbers Six month period ending 30 Sept 31 March 30 Sept 31 March 30 Sept 31 March 30 Sept Persons All ages 16,810 23,916 28,599 28,499 30,545 31,815 33,093 Under to 19 1,756 3,170 3,923 3,896 4,404 4,217 4, to 24 4,489 6,340 7,522 7,421 8,167 8,241 8, to 29 4,605 6,338 7,339 7,294 7,571 7,959 8, to 34 2,778 4,197 5,030 5,088 5,219 5,765 6, to 39 1,526 1,997 2,534 2,568 2,744 3,040 3, to ,119 1,127 1,234 1,287 1, to to to to and over Males All ages 12,556 18,055 21,343 21,428 22,925 23,635 24,332 Under to 19 1,244 2,233 2,733 2,810 3,078 2, to 24 3,413 4,773 5,562 5,510 6,032 5, to 29 3,515 4,946 5,613 5,600 5,826 6, to 34 2,117 3,290 3,875 3,922 4,031 4, to 39 1,163 1,495 1,920 1,936 2,105 2, to to to to to and over Females All ages 4,254 5,861 7,256 7,071 7,620 8,180 8,761 Under to ,190 1,086 1,326 1, to 24 1,076 1,567 1,960 1,911 2,135 2, to 29 1,090 1,392 1,726 1,694 1,745 1, to ,155 1,166 1,188 1, to to to to to to and over There was a change in reporting practice for the period ending March RDMDs were specifically asked to exclude 'prison episodes' from their submission of data to DH. Taking account of these 'prison episodes', the number of episodes increased by around 8% between the periods ending Sept 1999 and March 2000 (see also paragraph 2.4)

Statistics from the Regional Drug Misuse Databases for six months ending March 2001

Statistics from the Regional Drug Misuse Databases for six months ending March 2001 Statistics from the Regional Drug Misuse Databases for six months ending March 2001 This bulletin summarises information on people presenting to services with problem drug misuse and relates to the six

More information

Statistics from the Northern Ireland Drug Misuse Database: 1 April March 2012

Statistics from the Northern Ireland Drug Misuse Database: 1 April March 2012 Statistics from the Northern Ireland Drug Misuse Database: 1 April 2011 31 March 2012 This bulletin summarises information on people presenting to services with problem drug misuse and relates to the 12-month

More information

Statistics from the Northern Ireland Drug Misuse Database: 1 April March 2011

Statistics from the Northern Ireland Drug Misuse Database: 1 April March 2011 Statistics from the Northern Ireland Drug Misuse Database: 1 April 2010 31 March 2011 This bulletin summarises information on people presenting to services with problem drug misuse and relates to the 12-month

More information

Statistics on young people and drug misuse: England, 2000 and 2001

Statistics on young people and drug misuse: England, 2000 and 2001 Statistics on young people and drug misuse: England, 2000 and 2001 This bulletin presents information on reported drug misuse among young people aged under 25 years from two key published sources. Information

More information

Statistics on Drug Misuse: England, 2007

Statistics on Drug Misuse: England, 2007 Statistics on Drug Misuse: England, 2007 Summary For the first time, this annual statistical bulletin presents information on drug misuse among both adults and children. The topics covered include: Prevalence

More information

Statistics on Drug Misuse: England, 2008

Statistics on Drug Misuse: England, 2008 Statistics on Drug Misuse: England, 2008 Summary This annual statistical report presents information on drug misuse among both adults and children. It includes a focus on young adults. The topics covered

More information

Trends in treated problem cannabis use in the seven health board areas outside the Eastern Regional Health Authority, 1998 to 2002

Trends in treated problem cannabis use in the seven health board areas outside the Eastern Regional Health Authority, 1998 to 2002 Drug Misuse Resear ch Divisio n Contents - Summary - Glossary of terms - Introduction - Methods - Analysis Trends in treated problem cannabis use in the seven health board areas outside the Eastern Regional

More information

Substance misuse among young people The data for

Substance misuse among young people The data for Substance misuse among young people The data for 28-9 EFFECTIVE TREATMENT CHANGING LIVES www.nta.nhs.uk Substance misuse among young people The data for 28-9 More teenagers are receiving help for drug

More information

Statistics on Drug Misuse: England, 2012

Statistics on Drug Misuse: England, 2012 Statistics on Drug Misuse: England, 2012 Copyright 2012, The Health and Social Care Information Centre. All Rights Reserved. Copyright 2012, The Health and Social Care Information Centre. All Rights Reserved.

More information

Drug Misuse Research Division

Drug Misuse Research Division Drug Misuse Research Division Contents Occasional Paper p No. 12/ 9/ 2003 2004 Trends in treated problem drug use in the seven health board areas outside the Eastern Regional Health Authority, 1998 to

More information

Statistics on Smoking Cessation Services in Northern Ireland: 2008/2009

Statistics on Smoking Cessation Services in Northern Ireland: 2008/2009 Statistics on Smoking Cessation Services in Northern Ireland: 2008/2009 This information release, produced by the Department of Health, Social Services and Public Safety s Information and Analysis Directorate,

More information

Dual Diagnosis. Themed Review Report 2006/07 SHA Regional Reports East Midlands

Dual Diagnosis. Themed Review Report 2006/07 SHA Regional Reports East Midlands Dual Diagnosis Themed Review Report 2006/07 SHA Regional Reports East Midlands Contents Foreword 1 Introduction 2 Recommendations 2 Themed Review 06/07 data 3 Additional information 13 Weighted population

More information

Drug Misuse Research Division

Drug Misuse Research Division Drug Misuse Research Division contents Occasional Paper No. 1/ 2002 - Background - NDTRS methodology - Treatment as an indicator of drug misuse - Treatment provision - Extent of the problem - Socio-demographic

More information

Statistics on Drug Misuse: England, 2009

Statistics on Drug Misuse: England, 2009 Statistics on Drug Misuse: England, 2009 Copyright 2009, The Health and Social Care Information Centre. All Rights Reserved. The NHS Information Centre is England s central, authoritative source of health

More information

ALCOHOL RELATED DEATHS REGISTERED IN NORTHERN IRELAND ( )

ALCOHOL RELATED DEATHS REGISTERED IN NORTHERN IRELAND ( ) ALCOHOL RELATED DEATHS REGISTERED IN NORTHERN IRELAND (1999-2009) 9.30am Thursday, 16 December 2010 Introduction 1. This report looks at the most recent official death registration data available on alcohol

More information

Treated problem drug use in Ireland: Figures for 2007 from the National Drug Treatment Reporting System

Treated problem drug use in Ireland: Figures for 2007 from the National Drug Treatment Reporting System Treated problem drug use in Ireland: Figures for 2007 from the National Drug Treatment Reporting System Alcohol and Drug Research Unit, Health Research Board, March 2009 Summary Significant improvements

More information

Alcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire.

Alcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire. Alcohol and Drug Commissioning Framework for Northern Ireland 2013-16 Consultation Questionnaire. This questionnaire has been designed to help stakeholders respond to the above framework. Written responses

More information

Treated problem drug use in Ireland figures from the National Drug Treatment Reporting System

Treated problem drug use in Ireland figures from the National Drug Treatment Reporting System Treated problem drug use in Ireland 2008 figures from the National Drug Treatment Reporting System Alcohol and Drug Research Unit Health Research Board, January 2010 Summary Significant improvements in

More information

Statistics on Smoking Cessation Services in Northern Ireland: 2014/15

Statistics on Smoking Cessation Services in Northern Ireland: 2014/15 Statistics on Smoking Cessation Services in Northern Ireland: 2014/15 Statistical Bulletin Published October 2015 Statistics on Smoking Cessation Services in Northern Ireland: 2014/15 Author: Mervyn Wilson

More information

The adult social care workforce supporting people with learning disabilities and/or autism Data from the National Minimum Data Set for Social Care

The adult social care workforce supporting people with learning disabilities and/or autism Data from the National Minimum Data Set for Social Care The adult social care workforce supporting people with learning disabilities and/or autism Data from the National Minimum Data Set for Social Care July 2016 2 The adult social care workforce supporting

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification

More information

Home Office Statistical Bulletin

Home Office Statistical Bulletin Home Office Statistical Bulletin The Research, Development and Statistics Directorate exists to improve policy making, decision taking and practice in support of the Home Office purpose and aims, to provide

More information

PUBLIC HEALTH INTERVENTION GUIDANCE SCOPE

PUBLIC HEALTH INTERVENTION GUIDANCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE PUBLIC HEALTH INTERVENTION GUIDANCE 1 Guidance title SCOPE Interventions delivered in primary and secondary schools to prevent and/or reduce alcohol

More information

Statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April March 2012

Statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April March 2012 Statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2011 31 March 2012 4th October 2012 Vol. 1: The Numbers Executive Summary Of the 197,110 clients aged 18 and over in treatment

More information

Medical Device Alert. Device Non CE-marked portable dental X-ray units. Including the Tianjie Dental Falcon. Action by

Medical Device Alert. Device Non CE-marked portable dental X-ray units. Including the Tianjie Dental Falcon. Action by Medical Device Alert Issued: 16 July 2012 at 15:30 Device Non CE-marked portable dental X-ray units. Including the Tianjie Dental Falcon. Problem Testing by the Health Protection Agency (HPA) has revealed

More information

Police Recorded Drug Seizure and Arrest Statistics

Police Recorded Drug Seizure and Arrest Statistics Police Service of Northern Ireland Police Recorded Drug Seizure and Arrest Statistics Annual Report covering the period 1 st April 2014 31 st March 2015 Published 12 th May 2015 Contact: Drug Seizure Statistician

More information

Take Home Naloxone Report on supply and use to reverse an overdose

Take Home Naloxone Report on supply and use to reverse an overdose Take Home Naloxone Report on supply and use to reverse an overdose 2012-2016 1 Contents 1. Introduction 2. How the Take Home Naloxone Programme works 3. How information is collected 4. Patients supplied

More information

NATIONAL AND REGIONAL ESTIMATES OF THE PREVALENCE OF OPIATE AND/OR CRACK COCAINE USE : A SUMMARY OF KEY FINDINGS

NATIONAL AND REGIONAL ESTIMATES OF THE PREVALENCE OF OPIATE AND/OR CRACK COCAINE USE : A SUMMARY OF KEY FINDINGS Information about the number of people who use illicit drugs is key to formulating effective policies for tackling drug-related harm NATIONAL AND REGIONAL ESTIMATES OF THE PREVALENCE OF OPIATE AND/OR CRACK

More information

Northern Ireland Substitute Prescribing Database Report 31 st March 2013

Northern Ireland Substitute Prescribing Database Report 31 st March 2013 Northern Ireland Substitute Prescribing Database Report 31 st March 2013 Contents Statistics from the Northern Ireland Substitute Prescribing Database: 31 March 2013... 3 Standards and Guidelines... 4

More information

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes PH52 Audit tool for the implementation of NICE public health guidance 52 Needle and syringe programmes Introduction This audit tool has been developed to help you audit implementation of, and compliance

More information

PLEASE COMPLETE ALL RELEVANT SECTIONS OF THIS FORM

PLEASE COMPLETE ALL RELEVANT SECTIONS OF THIS FORM APPLICATION FOR INCLUSION IN THE DENTAL LIST OF THE HEALTH AND SOCIAL CARE BOARD PLEASE COMPLETE ALL RELEVANT SECTIONS OF THIS FORM Return the completed form to the Health and Social Care Board local office

More information

Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2014/15: Sweep 11 report

Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2014/15: Sweep 11 report September 2017 Updated July 2018 Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2014/15: Sweep 11 report Gordon Hay 1, Anderson Rael dos Santos 2, Zoe Swithenbank 1 1. Public Health

More information

Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2008/09: Sweep 5 report

Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2008/09: Sweep 5 report Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2008/09: Sweep 5 report Project team: Gordon Hay 1 Maria Gannon 1 Jane Casey 1 Tim Millar 2 Produced by 1- The Centre for Drug Misuse

More information

Rebbecca Aust and Nicola Smith

Rebbecca Aust and Nicola Smith The Research, Development and Statistics Directorate exists to improve policy making, decision taking and practice in support of the Home Office purpose and aims, to provide the public and Parliament with

More information

Dr Vivian Hope. Health Protection Agency, London. 19 th Annual Conference of the British HIV Association (BHIVA)

Dr Vivian Hope. Health Protection Agency, London. 19 th Annual Conference of the British HIV Association (BHIVA) 19 th Annual Conference of the British HIV Association (BHIVA) Dr Vivian Hope Health Protection Agency, London 16-19 April 2013, Manchester Central Convention Complex Prevalence of, and risk factors for,

More information

Drug and alcohol treatment in the North West of England 2008/09. Results from the National Drug Treatment Monitoring System (NDTMS)

Drug and alcohol treatment in the North West of England 2008/09. Results from the National Drug Treatment Monitoring System (NDTMS) Drug and alcohol treatment in the North West of England 2008/09 Results from the National Drug Treatment Monitoring System (NDTMS) Drug and alcohol treatment in the North West of England 2008/09 - Results

More information

BROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes.

BROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes. 13. Substance Misuse Introduction Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes. The term substance misuse often refers to illegal drugs, but, some

More information

Guidelines For Services Providing Injecting Equipment

Guidelines For Services Providing Injecting Equipment Guidelines For Services Providing Injecting Equipment Best Practice Recommendations For Commissioners and Injecting Equipment Provision (IEP) Services in Scotland (Scottish Government 2010) January 2014

More information

6: Service considerations a report from the Adult Dental Health Survey 2009

6: Service considerations a report from the Adult Dental Health Survey 2009 UK Data Archive Study Number - Adult Dental Health Survey, 009 6: Service considerations a report from the Adult Dental Health Survey 009 Copyright 0, The Health and Social Care Information Centre. All

More information

RE: ADVISORY PANEL ON SUBSTANCE MISUSE - REVIEW OF THE POLICY INTERVENTIONS NEEDED TO TACKLE SUBSTANCE MISUSE IN AN AGEING POPULATION

RE: ADVISORY PANEL ON SUBSTANCE MISUSE - REVIEW OF THE POLICY INTERVENTIONS NEEDED TO TACKLE SUBSTANCE MISUSE IN AN AGEING POPULATION Y Panel Cynghori ar Gamddefnyddio Sylweddau Advisory Panel on Substance Misuse To: See Distribution List Eich Cyf/Your Ref: Ein Cyf/Our Ref: 30 th January 2015 Dear Colleague, RE: ADVISORY PANEL ON SUBSTANCE

More information

POLICY AND GUIDANCE FOR MANAGERS ON STAFF SUBSTANCE MISUSE

POLICY AND GUIDANCE FOR MANAGERS ON STAFF SUBSTANCE MISUSE POLICY AND GUIDANCE FOR MANAGERS ON STAFF SUBSTANCE MISUSE HEALTH & SAFETY UNIT AUTUMN 2012 CONTENTS 1 INTRODUCTION... ERROR! BOOKMARK NOT DEFINED. 2 AIM... ERROR! BOOKMARK NOT DEFINED. 3 APPLICATION...

More information

Public Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta. Learning objectives

Public Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta. Learning objectives Public Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta Justine Fitzpatrick 19 th February 2008- Public Health WORKS Speaker Series Learning

More information

Drugs and Alcohol Abuse Policy

Drugs and Alcohol Abuse Policy Drugs and Alcohol Abuse Policy Introduction From the beginning of 2013, there are increased requirements to provide mandatory proof of inhouse drugs and alcohol testing procedures prior to employees being

More information

Alcohol Treatment in Cheshire and Merseyside, 2010/11

Alcohol Treatment in Cheshire and Merseyside, 2010/11 Alcohol Treatment in Cheshire and Merseyside, 2010/11 Ayesha Hurst, Adam Marr, Mark Whitfield and Jim McVeigh July 2012 Acknowledgements The authors would like to thank the following people for their help

More information

JSNA Substance Misuse

JSNA Substance Misuse JSNA Substance Misuse Introduction 9.1. Substance misuse causes less damage to health in absolute population terms than tobacco or alcohol. However, its association with crime and antisocial behaviour

More information

Transplant Activity in the UK

Transplant Activity in the UK Transplant Activity in the UK 2006-2007 This document has been produced by the Statistics and Audit Directorate. UK Transplant August 2007 Cover pictures: Members of Glamorgan County cricket team help

More information

Appendix 1: Data elements included in the AODTS NMDS for

Appendix 1: Data elements included in the AODTS NMDS for Appendixes Appendix 1: Data elements included in the AODTS NMDS for 2004 05 The detailed data definitions for the data elements included in the AODTS NMDS for 2004 05 are published in the National Health

More information

Substance use and misuse

Substance use and misuse An open learning programme for pharmacists and pharmacy technicians Substance use and misuse Educational solutions for the NHS pharmacy workforce DLP 160 Contents iii About CPPE open learning programmes

More information

National Drug and Alcohol Treatment Waiting Times Report

National Drug and Alcohol Treatment Waiting Times Report Publication Report National Drug and Alcohol Treatment Waiting Times Report October December 2016 Publication Date 28 March 2017 A National Statistics Publication for Scotland Contents Introduction...

More information

Evidence-based interventions for managing illicit drug dependence

Evidence-based interventions for managing illicit drug dependence Evidence-based interventions for managing illicit drug dependence Medical professionals have a key role to play in managing the harms (see Box 1) associated with illicit drug dependence. This can be in

More information

Dear Colleague GENERAL OPHTHALMIC SERVICES OPTOMETRY INDEPENDENT PRESCRIBING. Summary

Dear Colleague GENERAL OPHTHALMIC SERVICES OPTOMETRY INDEPENDENT PRESCRIBING. Summary NHS: PCA(O)(2013)4 Health and Social Care Integration Directorate Primary Care Division Dear Colleague GENERAL OPHTHALMIC SERVICES OPTOMETRY INDEPENDENT PRESCRIBING Summary 1. This letter advises NHS Boards

More information

abcdefghijklmnopqrstu

abcdefghijklmnopqrstu Chief Medical Officer and Public Health Directorate Public Health Division Dear Colleague MANAGEMENT OF PEOPLE IN THE COMMUNITY WHO ARE DRUNK AND INCAPABLE: A NATIONAL MEMORANDUM OF UNDERSTANDING BETWEEN

More information

Harm Reduction Database Wales: Needle and Syringe provision

Harm Reduction Database Wales: Needle and Syringe provision Harm Reduction Database Wales: Needle and Syringe provision 2012-13 Public Health Wales would like to thank all those that contributed to the Harm Reduction Database Wales: NSP service users, NSP staff

More information

National Drug and Alcohol Treatment Waiting Times

National Drug and Alcohol Treatment Waiting Times National Drug and Alcohol Treatment Waiting Times 1 October 31 December 2017 Publication date 27 March 2018 A National Statistics publication for Scotland This is a National Statistics Publication National

More information

2016 UK-wide summary

2016 UK-wide summary 206 UK-wide summary CRIDE report on 206 survey on educational provision for deaf children Introduction In 206, the Consortium for Research into Deaf Education (CRIDE) carried out its sixth annual survey

More information

Home Office Statistical Bulletin

Home Office Statistical Bulletin Home Office Statistical Bulletin The Research, Development and Statistics Directorate exists to improve policy making, decision taking and practice in support of the Home Office purpose and aims, to provide

More information

Young people s statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2013 to 31 March 2014

Young people s statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2013 to 31 March 2014 Young people s statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2013 to 31 March 2014 1 About Public Health England Public Health England exists to protect and improve the

More information

Data Flows for Direct Commissioning v1.54 Activity Reporting Programme Child Immunisations UNIFY Collections: Guidance

Data Flows for Direct Commissioning v1.54 Activity Reporting Programme Child Immunisations UNIFY Collections: Guidance Data Flows for Direct Commissioning (COVER) UNIFY Collections: Guidance v1.54 Activity Reporting Programme UNIFY Collections: Guidance Page 1 of 11 (COVER) UNIFY Collections: Guidance This document aims

More information

Survey of networks and arrangements for HIV clinical care

Survey of networks and arrangements for HIV clinical care 1 of 6 20/08/2007 16:40 Survey of networks and arrangements for HIV clinical care Please ensure that you have read the [add link] invitation letter [/add link] before completing this survey. When you have

More information

Female Genital Mutilation (FGM) Enhanced Dataset

Female Genital Mutilation (FGM) Enhanced Dataset Female Genital Mutilation (FGM) Enhanced Dataset April 2016 to March 2017, England, experimental statistics Published 4 July 2017 The Female Genital Mutilation (FGM) Enhanced Dataset (SCCI 2026) supports

More information

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Report of the Government of: Reporting Year: Completed on (date): Please return completed questionnaire to: arq@unodc.org

More information

Dental Earnings and Expenses: Scotland, 2011/12

Dental Earnings and Expenses: Scotland, 2011/12 Dental Earnings and Expenses: Published 25 October 2013 We are the trusted source of authoritative data and information relating to health and care. www.hscic.gov.uk enquiries@hscic.gov.uk Author: Responsible

More information

Quantifying Problematic Drug Use Within Liverpool and Sefton Drug [and Alcohol] Action Teams (2000/1 and 2001/2)

Quantifying Problematic Drug Use Within Liverpool and Sefton Drug [and Alcohol] Action Teams (2000/1 and 2001/2) Quantifying Problematic Drug Use Within Liverpool and Sefton Drug [and Alcohol] Action Teams (2000/1 and 2001/2) Capture-Recapture Analysis April 2004 Caryl Beynon, Jim McVeigh and Mark Bellis Centre for

More information

Hospital Caterers Association

Hospital Caterers Association Hospital Caterers Association www.hospitalcaterers.org Patron Application Pack 1 Contents What is the Hospital Caterers Association? 3 Branches of The Association 4 Why become a Patron 5 How to join 6

More information

Evaluation report for The Advocacy Project. Executive Summary

Evaluation report for The Advocacy Project. Executive Summary Evaluation report for The Advocacy Project Executive Summary 2015 Acknowledgements We were privileged to have had this opportunity to spend time at The Advocacy Project and to learn more about the valuable

More information

Police Recorded Drug Seizures and Arrests in Northern Ireland: Monthly Update to 31 March 2018

Police Recorded Drug Seizures and Arrests in Northern Ireland: Monthly Update to 31 March 2018 Police Service of Northern Ireland Police Recorded Drug Seizures and Arrests in Northern Ireland: Monthly Update to 31 March 218 (Providing figures for 1 April 217 to 31 March 218) Published 17 May 218

More information

Injecting Equipment Provision in Scotland Survey 2011/12

Injecting Equipment Provision in Scotland Survey 2011/12 Publication Report Injecting Equipment Provision in Scotland Survey 25 June 2013 An Official Statistics Publication for Scotland Contents Introduction... 2 Key points... 3 Results and Commentary... 4 1.

More information

FINAL REPORT CT.98.EP.04

FINAL REPORT CT.98.EP.04 E.M.C.D.D.A. FINAL REPORT PILOT PROJECT TO DEVELOP A MODEL OF GEOGRAPHICAL SPREAD OF DRUG MISUSE IN THE EUROPEAN UNION CT.98.EP.04 Department of Medicines Management, Keele University Other Contributors

More information

Police Recorded Drug Seizure and Arrest Statistics: Monthly Update to 31 January 2016

Police Recorded Drug Seizure and Arrest Statistics: Monthly Update to 31 January 2016 Police Service of Northern Ireland Police Recorded Drug Seizure and Arrest Statistics: Monthly Update to 216 Published 17 February 216 Police Recorded Drug Seizure and Arrest Statistics Published 17 February

More information

Police Service of Northern Ireland. Police Recorded Drug Seizures and Arrests in Northern Ireland: Update to 30 September 2018

Police Service of Northern Ireland. Police Recorded Drug Seizures and Arrests in Northern Ireland: Update to 30 September 2018 Police Service of Northern Ireland Police Recorded Drug Seizures and Arrests in Northern Ireland: Update to Published 31 October 1 Police Recorded Drug Seizures and Arrests in Northern Ireland Published

More information

Hospital Caterers Association

Hospital Caterers Association Hospital Caterers Association www.hospitalcaterers.org Patron Application Pack 1 Contents What is the Hospital Caterers Association? 3 Branches of The Association 4 Why become a Patron 5 How to join 6

More information

Substance use among year olds in the UK: Key findings from the 2011 European Survey Project on Alcohol and Drugs (ESPAD)

Substance use among year olds in the UK: Key findings from the 2011 European Survey Project on Alcohol and Drugs (ESPAD) Substance use among 15-16 year olds in the UK: Key findings from the 2011 European Survey Project on Alcohol and Drugs (ESPAD) Amanda M. Atkinson, Harry R. Sumnall & Mark A. Bellis 1. Introduction The

More information

Drug-related deaths and deaths among drug users in Ireland figures from the National Drug-Related Deaths Index

Drug-related deaths and deaths among drug users in Ireland figures from the National Drug-Related Deaths Index Drug-related deaths and deaths among drug users in Ireland 21 figures from the National Drug-Related Deaths Index January 213 Summary of 21 results This update presents figures from the National Drug-Related

More information

EMCDDA looks behind rising numbers of young people in cannabis treatment

EMCDDA looks behind rising numbers of young people in cannabis treatment 2004 ANNUAL REPORT: SELECTED ISSUES EMCDDA looks behind rising numbers of young people in cannabis treatment (25.11.2004 LISBON EMBARGO 10H00 CET/Brussels time) Specialised drug treatment centres in many

More information

Northern Ireland Substitute Prescribing Database Report 31 st March 2015

Northern Ireland Substitute Prescribing Database Report 31 st March 2015 Northern Ireland Substitute Prescribing Database Report 31 st March 2015 1 Contents Statistics from the Northern Ireland Substitute Prescribing Database: 31st March 2015... 3 Summary... 3 Summary of activity

More information

SHRUGs national report Information & Statistics Division The National Health Service in Scotland Edinburgh June 2000

SHRUGs national report Information & Statistics Division The National Health Service in Scotland Edinburgh June 2000 Scottish Health Resource Utilisation Groups SHRUGs national report 1999 Information & Statistics Division The National Health Service in Scotland Edinburgh June 2000 Contents -- click on the section of

More information

National Drug and Alcohol Treatment Waiting Times

National Drug and Alcohol Treatment Waiting Times National Drug and Alcohol Treatment Waiting Times 1 April 30 June 2018 Publication date 25 September 2018 A National Statistics publication for Scotland This is a National Statistics Publication National

More information

BARNSLEY METROPOLITAN BOROUGH COUNCIL

BARNSLEY METROPOLITAN BOROUGH COUNCIL BARNSLEY METROPOLITAN BOROUGH COUNCIL This matter is a Key Decision within the Council s definition and has been included in the relevant Forward Plan Report of the Executive Director (People) to Cabinet

More information

2. Morbidity. Incidence

2. Morbidity. Incidence 2. Morbidity This chapter reports on country-level estimates of incidence, case fatality and prevalence of the following conditions: myocardial infarction (heart attack), stroke, angina and heart failure.

More information

8.0 Take Home Naloxone

8.0 Take Home Naloxone 8.0 Take Home Naloxone 8.1 Population characteristics For the financial year (FY) 2016/17, 721 take home naloxone (THN) kits were issued in the City of Edinburgh. Of the 323 individuals who received naloxone

More information

Evaluation of the Health and Social Care Professionals Programme Interim report. Prostate Cancer UK

Evaluation of the Health and Social Care Professionals Programme Interim report. Prostate Cancer UK Evaluation of the Health and Social Care Professionals Programme Interim report Prostate Cancer UK July 2014 Contents Executive summary... 2 Summary of the research... 2 Main findings... 2 Lessons learned...

More information

Survey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX

Survey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX European Surveillance of Sexually Transmitted Infections Survey questionnaire on STI surveillance, care and prevention in European countries APPENDIX Detailed questionnaire on clinician and laboratory

More information

Mental Health Strategy. Easy Read

Mental Health Strategy. Easy Read Mental Health Strategy Easy Read Mental Health Strategy Easy Read The Scottish Government, Edinburgh 2012 Crown copyright 2012 You may re-use this information (excluding logos and images) free of charge

More information

Table 1. Synthetic Estimate for Abstaining from Drinking in Shropshire. Abstaining from Drinking Proportion

Table 1. Synthetic Estimate for Abstaining from Drinking in Shropshire. Abstaining from Drinking Proportion 1 Adult Alcohol Misuse in Shropshire 2013/14 Prevalence of Drinking in Shropshire Who abstains from drinking in Shropshire? Table 1 shows the synthetic estimate of the percentage of the population of Shropshire

More information

Dementia Advisers Survey

Dementia Advisers Survey February 2016 Dementia Advisers Survey Survey of provision of dementia adviser services Ipsos MORI Ipsos MORI February 2016 Version 1 Final Public 2 Dementia Advisers Report Version 1 Public This work

More information

provides services for drug and alcohol users, families and carers.

provides services for drug and alcohol users, families and carers. provides services for drug and alcohol users, families and carers. Blenheim s mission is to end dependency by enabling people to change. Along the way we also improve people s health and quality of life

More information

WELSH GOVERNMENT RESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO NEW PSYCHOACTIVE SUBSTANCES

WELSH GOVERNMENT RESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO NEW PSYCHOACTIVE SUBSTANCES WELSH GOVERNMENT RESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO NEW PSYCHOACTIVE SUBSTANCES Recommendation 1 The Committee recommends that the Minister for Health and

More information

The National perspective Public Health England s vision, mission and priorities

The National perspective Public Health England s vision, mission and priorities The National perspective Public Health England s vision, mission and priorities Dr Ann Hoskins Director Children, Young People and Families Public Health England May 2013 Mission Public Health England

More information

Addiction and Substance misuse pathways

Addiction and Substance misuse pathways Addiction and Substance misuse pathways Gordon Morse Chief Medical Officer Turning Point UK Gordon Morse statement of interests Sole employer Turning Point Some unpaid advisory work to the Hepatitis C

More information

Enter & View WDP Havering Drug and alcohol dependency services 11 October 2016

Enter & View WDP Havering Drug and alcohol dependency services 11 October 2016 Enter & View WDP Havering Drug and alcohol dependency services 11 October 2016 Healthwatch Havering is the operating name of Havering Healthwatch Limited A company limited by guarantee Registered in England

More information

Quality care. Everywhere? An audit of prostate cancer services in the UK

Quality care. Everywhere? An audit of prostate cancer services in the UK Quality care. Everywhere? An audit of prostate cancer services in the UK Foreword Why should a man who lives in Essex receive worse care and support for prostate cancer than a man who comes from Manchester?

More information

6.1.2 Other multi-agency groups which feed into the ADP and support the on-going work includes:

6.1.2 Other multi-agency groups which feed into the ADP and support the on-going work includes: 6. ALCOHOL AND DRUGS PLANNING FRAMEWORK 6.1 Analysis of Local Position 6.1.1 The Alcohol and Drug Partnership (ADP) in Renfrewshire has responsibility for local planning of alcohol and drug services. ADPs

More information

Understanding Alcohol Misuse in Scotland HARMFUL DRINKING. Three: Alcohol and Self-harm

Understanding Alcohol Misuse in Scotland HARMFUL DRINKING. Three: Alcohol and Self-harm Scottish Emergency Department Alcohol AuditSEDAA Understanding Alcohol Misuse in Scotland HARMFUL DRINKING Three: Alcohol and Self-harm Scottish Emergency Department Alcohol AuditSEDAA Understanding Alcohol

More information

National Cancer Patient Experience Survey Results. University Hospitals of Leicester NHS Trust. Published July 2016

National Cancer Patient Experience Survey Results. University Hospitals of Leicester NHS Trust. Published July 2016 National Cancer Patient Experience Survey 2015 Results University Hospitals of Leicester NHS Trust Published July 2016 Revised 17th August 2016 The National Cancer Patient Experience Survey is undertaken

More information

Healthwatch Bristol summary of the Bristol Health and Wellbeing Board meeting on 15 February 2017

Healthwatch Bristol summary of the Bristol Health and Wellbeing Board meeting on 15 February 2017 Healthwatch Bristol summary of the Bristol Health and Wellbeing Board meeting on 15 February 2017 Healthwatch Bristol has a seat on the Health and Wellbeing Board to represent the views of people living

More information

CABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND

CABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND CABINET Report No: 105/2017 PUBLIC REPORT 16 May 2017 PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND Report of the Director of Public Health Strategic Aim: Safeguarding Key Decision:

More information

Census of Drug and Alcohol Treatment Services. Lifestyle. in Northern Ireland 1 st March 2017

Census of Drug and Alcohol Treatment Services. Lifestyle. in Northern Ireland 1 st March 2017 Census of Drug and Alcohol Treatment Services Lifestyle in Northern Ireland 1 st March 2017 Published 1 st August 2017 Census of Drug and Alcohol Treatment Services in Northern Ireland 1 st March 2017

More information

National Cancer Patient Experience Survey Results. East Kent Hospitals University NHS Foundation Trust. Published July 2016

National Cancer Patient Experience Survey Results. East Kent Hospitals University NHS Foundation Trust. Published July 2016 National Cancer Patient Experience Survey 2015 Results East Kent Hospitals University NHS Foundation Trust Published July 2016 Revised 17th August 2016 The National Cancer Patient Experience Survey is

More information